Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.

OBJECTIVE: To investigate the proportion of patients starting on either selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) who continued treatment for a period consistent with recommended guidelines for major depression, that is at least 6 months. METHOD: Cohort stud...

Descripción completa

Detalles Bibliográficos
Publicado en:Australian & New Zealand Journal of Psychiatry Vol. 38; no. 6; pp. 450 - 455
Autores principales: McManus P, Mant A, Mitchell P, Dudley J
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. Jun2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106547260&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106547260
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00048674
        7ZU
      jtl: Australian & New Zealand Journal of Psychiatry
      issn: 00048674
      maglogo: Y
    pubinfo:
      dt: Jun2004
      vid: 38
      iid: 6
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        106547260
        106547260
        2009061577
        10.1080/j.1440-1614.2004.01383.x
        NLM15209838
        106547260
      ppf: 450
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.
      aug:
        au:
          McManus P
          Mant A
          Mitchell P
          Dudley J
        affil: Department of Health and Ageing, Canberra, ACT, Australia; peter.mcmanus@health.gov.au
      sug:
        subj:
          Antidepressive Agents, Tricyclic Therapeutic Use
          Psychopharmacology Standards
          Serotonin Uptake Inhibitors Therapeutic Use
          Treatment Duration Standards
          Antidepressive Agents Therapeutic Use
          Australia
          Data Analysis Software
          Databases
          Descriptive Statistics
          Insurance, Health
          Prospective Studies
          Human
      ab: OBJECTIVE: To investigate the proportion of patients starting on either selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) who continued treatment for a period consistent with recommended guidelines for major depression, that is at least 6 months. METHOD: Cohort study using a national dispensing claims database involving patients eligible for social security entitlements in Australia. Two 'new user' cohorts were established of patients who were supplied a prescription for either an SSRI (6026) or a TCA (4158) in the first week of April 2000 and who had not received a prescription for any antidepressant in the preceding three months. The main outcome measure was the proportion of patients who were still having any SSRI or TCA prescription, respectively, dispensed between 6 and 8 months after initiation. Additionally, for patients starting on either a leading SSRI (sertraline) or TCA (dothiepin), the proportions of those that remained on these drugs or had changed to other antidepressants were determined. The dispensing data are not linked to reason for prescribing in the national dataset. RESULTS: 2267 SSRI 'new users' (38%) were still receiving SSRIs 6-8 months later, compared with 1269 (31%) of the 4158 TCA 'new users' (p < 0.001). The difference between the groups occurred early, by the 2-4 month time interval. 1038 (41%) of patients starting on the individual SSRI and 385 (38%) of patients starting on the individual TCA were receiving some type of antidepressant therapy at 6-8 months, with no significant difference (p = 0.6) in the proportions that had changed to another antidepressant. CONCLUSIONS: In 2000, only 40% of patients started on an antidepressant continued to be prescribed some antidepressant therapy 6-8 months later. Patients were more likely to continue on SSRIs as a class than on TCAs and the difference in continuation between these two classes occurred within the first 2 months of therapy. However, patients starting on an individual SSRI or TCA were equally likely to change to another antidepressant.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N